Moderna, Inc.
MRNA
$26.26
-$0.46-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.30% | -8,715.38% | 101.02% | -8.85% | -641.47% |
| Total Depreciation and Amortization | -35.00% | 15.38% | 26.83% | 13.89% | -82.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.38% | 51.02% | -10.91% | 22.22% | 110.30% |
| Change in Net Operating Assets | -112.15% | 200.46% | -1,084.25% | -343.33% | -94.43% |
| Cash from Operations | -225.70% | 152.68% | -22.92% | -28.82% | -259.00% |
| Capital Expenditure | 77.59% | -245.70% | 17.03% | 7.14% | 10.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5,082.35% | -101.95% | -52.38% | 483.12% | 198.74% |
| Cash from Investing | 235.44% | -174.76% | -56.28% | 1,297.46% | 121.93% |
| Total Debt Issued | 150.00% | -233.33% | 200.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | 200.00% | 99.19% |
| Issuance of Common Stock | -72.73% | 37.50% | -75.00% | 113.33% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 233.33% | -127.27% | -67.65% | 142.86% | 112.84% |
| Foreign Exchange rate Adjustments | -- | -200.00% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -207.45% | 133.85% | -303.67% | 147.72% | -3,328.00% |